Sirona Biochem Corp Stock Today
| SRBCF Stock | USD 0.01 0 28.14% |
PerformanceVery Weak
| Odds Of DistressLow
|
Sirona Biochem is trading at 0.012 as of the 14th of March 2025. This is a 28.14% down since the beginning of the trading day. The stock's lowest day price was 0.0019. Sirona Biochem has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 14th of December 2024 and ending today, the 14th of March 2025. Click here to learn more.
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. The company was incorporated in 2006 and is headquartered in Vancouver, Canada. Sirona Biochem is traded on OTC Exchange in the United States.. The company has 251.73 M outstanding shares. More on Sirona Biochem Corp
Moving against Sirona Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Sirona Pink Sheet Highlights
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Sirona Biochem Corp [SRBCF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Micro-Cap' category with a current market capitalization of 20.74 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sirona Biochem's market, we take the total number of its shares issued and multiply it by Sirona Biochem's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sirona Biochem Corp classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 251.73 M outstanding shares.
Sirona Biochem Corp has accumulated about 1.13 M in cash with (2.16 M) of positive cash flow from operations.
Check Sirona Biochem Probability Of Bankruptcy
Ownership AllocationSirona Biochem Corp shows a total of 251.73 Million outstanding shares. Sirona Biochem Corp has 10.43 % of its outstanding shares held by insiders and 0.0 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sirona Ownership Details
Sirona Biochem Corp Risk Profiles
| Mean Deviation | 4.42 | |||
| Standard Deviation | 8.65 | |||
| Variance | 74.81 | |||
| Risk Adjusted Performance | (0.16) |
Sirona Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sirona Biochem without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
Sirona Biochem Corporate Management
| CPA CGA | CFO Director | Profile | |
| Graldine DeliencourtGodefroy | Chief Director | Profile | |
| Michelle MBA | VP Operations | Profile | |
| Brett Premack | Scientific Consultant | Profile |
Other Information on Investing in Sirona Pink Sheet
Sirona Biochem financial ratios help investors to determine whether Sirona Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sirona with respect to the benefits of owning Sirona Biochem security.